HawaiiRELATING TO TERMINAL ILLNESSES.
What it does
Authorizes manufacturers of investigational drugs or biological products that are pending approval by the United States Food and Drug Administration to make the drugs or products available to terminally ill patients under certain conditions.
Where do you stand?
Choose your position
Tell your reps
Take a position to see your representatives and ways to contact them.
Where it stands
- Introduced
- Passed Senate
- Passed House
- To Governor
- Became Law
Looking ahead
No hearings or votes scheduled.
History
- 2026
- Jan 26Referred to HHS, CPN/JDC.Latest
- Jan 21Introduced and passed First Reading.Minor
- Jan 14Pending Introduction.Introduced